Catena Biosciences
PrivateLast Round
Seed
Jun 8, 2024
Est. Valuation
$10M
Total Funding Raised
$10.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Catena Biosciences is a biotechnology company that develops novel therapeutics using a proprietary protein conjugation platform called CysTyr™ to create Multi-Payload Conjugates (MPCs) for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Catena Biosciences Comparables
Compare Catena Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VALANX Biotech | 83% | |
| Taiho Pharmaceutical Co., Ltd. | 78% | |
| Pinotbio | 76% | |
Catena Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 8, 2024 | ||||
| Seed | May 7, 2024 | ||||
| Grant | Sep 17, 2021 | ||||
| Seed | Aug 1, 2021 | ||||
| Pre Seed | Apr 21, 2021 |
Catena Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Seed |
| Pioneer Fund | Seed |
| NIH RADx | Grant |
| Gaingels | Seed |
| BrightEdge | Seed |
| California Innovation Fund | Seed |
| Social Impact Capital | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 42% MoM.
- Aug 1, 2021
$5M round with participation from Amgen and Gaingels.
Catena Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Catena Biosciences's valuation, stock price, and market status.